Vaxil Bio Enters Into Letter of Intent With Green Data in Respect of A Proposed Reverse Takeover
GlobeNewswire
*Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or..
*Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or..
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage biotechnology company..
*SHERIDAN, WY / ACCESSWIRE / February 7, 2024 / *Buyer Group International, Inc. (OTC PINK:BYRG) is pleased to announce the signing..